Cargando…

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up

PURPOSE: Women with breast cancer (BC) often suffer from severe vulvovaginal atrophy (VVA) which ultimately leads to poor sexual and urinary quality of life. We conducted a prospective study among women with BC and VVA, in order to evaluate the long-term effect of laser therapy on VVA. METHODS: Wome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veron, Lucie, Wehrer, Delphine, Annerose-Zéphir, Gisèle, Suciu, Voichita, Delaloge, Suzette, Pistilli, Barbara, Chaltiel, Dan, Pautier, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062616/ https://www.ncbi.nlm.nih.gov/pubmed/33891298 http://dx.doi.org/10.1007/s10549-021-06226-3

Ejemplares similares

Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up
por: Ghanbari, Zinat, et al.
Publicado: (2020)

New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review
por: Benini, Vittoria, et al.
Publicado: (2022)

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies
por: Salcedo, Félix Lugo, et al.
Publicado: (2020)

Update on alternative therapies for vulvovaginal atrophy
por: Chollet, Janet A
Publicado: (2011)

Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2021)

Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
por: Sarmento, Ayane Cristine Alves, et al.
Publicado: (2021)

Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
por: Parish, Sharon J, et al.
Publicado: (2013)

Fractional CO(2) laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women
por: Arroyo, César
Publicado: (2017)

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy
por: Shin, Jae Jun, et al.
Publicado: (2017)

Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause
por: Kamronrithisorn, Thawinee, et al.
Publicado: (2020)

Treatment to External Labia and Vaginal Canal With CO(2) Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women
por: Samuels, Julene B, et al.
Publicado: (2019)

A systematic review of laser therapy for vulvovaginal atrophy/genitourinary syndrome of menopause in breast cancer survivors
por: Knight, Charity, et al.
Publicado: (2019)

Clinical Efficacy of Hormonal and Nonhormonal Agents in the Treatment of Vulvovaginal Atrophy
por: Ilhan, Gokcen, et al.
Publicado: (2021)

Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic
por: Suciu, Voichita, et al.
Publicado: (2023)

Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy
por: Diedrich, Chantal M., et al.
Publicado: (2019)

Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats
por: Ismail, Nur Hilwani, et al.
Publicado: (2023)

Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study
por: Rodríguez, Silvia Pilar González
Publicado: (2020)

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)
por: Sobel, R, et al.
Publicado: (2021)

The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state‐of‐the‐art review
por: Mortensen, Olivia Engholt, et al.
Publicado: (2022)

Vulvovaginitis/
por: Sarmineto Larrazabal, María Elena
Publicado: (1993)

Vulvovaginitis
por: Granda Mendoza, Norma
Publicado: (1987)

Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women
por: Nappi, Rossella E., et al.
Publicado: (2019)

Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study
por: Palacios, Santiago, et al.
Publicado: (2019)

Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy
por: Lázaro-Carrasco de la Fuente, Jesús, et al.
Publicado: (2022)

Three-Dimensional Heads-up Cataract Surgery Using Femtosecond Laser: Efficiency, Efficacy, Safety, and Medical Education—A Randomized Clinical Trial
por: Wang, Kai, et al.
Publicado: (2021)

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
por: Moy, Beverly, et al.
Publicado: (2021)

Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
por: Edwards, D., et al.
Publicado: (2016)

Vulvovaginal Trichosporonosis
por: Makela, Paul, et al.
Publicado: (2003)

Treatment of vulvovaginitis
por: Sheppard, Cate
Publicado: (2020)

2304: Identifying optimal multiple sclerosis (MS)-specific atrophy markers as primary endpoint for Phase II s in progressive MS
por: Azevedo, Christina, et al.
Publicado: (2018)

A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations
por: Rodón, Jordi, et al.
Publicado: (2022)

Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (*)
por: Nappi, Rossella E., et al.
Publicado: (2016)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer
por: Giudici, Fabiola, et al.
Publicado: (2023)

Dépistage et diagnostic du cancer du sein à la fin de période de confinement COVID-19, aspects pratiques et hiérarchisation des priorités()
por: Ceugnart, Luc, et al.
Publicado: (2020)

Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results
por: Lubián-López, Daniel M., et al.
Publicado: (2023)

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions
por: Rassy, Elie, et al.
Publicado: (2022)

Randomized, Double-Blind, Placebo-Controlled Study of Modified Erzhi Granules in the Treatment of Menopause-Related Vulvovaginal Atrophy
por: Chen, Ranran, et al.
Publicado: (2018)

Plurigin Ovules and Plurigin Solution in the Treatment of Vulvovaginal Atrophy in Menopausal Women: A Retrospective Monocentric Observational Study
por: Langella, Daniele
Publicado: (2023)

Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study
por: Donders, Gilbert, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nukjnkd9ibt3b4khd03m34pr13